Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 2
2006 2
2007 2
2008 1
2009 2
2010 2
2011 2
2012 4
2013 3
2014 1
2015 1
2016 1
2017 1
2018 1
2019 2
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
Performance characteristics of the VIDAS® ANTI-HEV IgM and IgG assays.
Abravanel F, Goutagny N, Joffray R, Eichenlaub E, Baron S, Aversenq A, Bourg S, Mercier L, Larue Triolet A, Poirault D, Loubet M, Daniel S, Luciani F, Pothion C, Tourneur C, Dugua JM, Lhomme S, Izopet J. Abravanel F, et al. Among authors: goutagny n. J Clin Virol. 2019 Mar;112:10-14. doi: 10.1016/j.jcv.2019.01.005. Epub 2019 Jan 11. J Clin Virol. 2019. PMID: 30658273
Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1β.
Ainouze M, Rochefort P, Parroche P, Roblot G, Tout I, Briat F, Zannetti C, Marotel M, Goutagny N, Auron P, Traverse-Glehen A, Lunel-Potencier A, Golfier F, Masson M, Robitaille A, Tommasino M, Carreira C, Walzer T, Henry T, Zanier K, Trave G, Hasan UA. Ainouze M, et al. Among authors: goutagny n. PLoS Pathog. 2018 Aug 8;14(8):e1007158. doi: 10.1371/journal.ppat.1007158. eCollection 2018 Aug. PLoS Pathog. 2018. PMID: 30089163 Free PMC article.
Evaluation of two VIDAS ®prototypes for detecting anti-HEV IgG.
Abravanel F, Goutagny N, Perret C, Lhomme S, Vischi F, Aversenq A, Chapel A, Dehainault N, Piga N, Dupret-Carruel J, Izopet J. Abravanel F, et al. Among authors: goutagny n. J Clin Virol. 2017 Apr;89:46-50. doi: 10.1016/j.jcv.2017.02.009. Epub 2017 Feb 24. J Clin Virol. 2017. PMID: 28249234
Pattern recognition receptors: an update.
Goutagny N, Fitzgerald KA. Goutagny N, et al. Expert Rev Clin Immunol. 2006 Jul;2(4):569-83. doi: 10.1586/1744666X.2.4.569. Expert Rev Clin Immunol. 2006. PMID: 20477614
TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression.
Parroche P, Roblot G, Le Calvez-Kelm F, Tout I, Marotel M, Malfroy M, Durand G, McKay J, Ainouze M, Carreira C, Allatif O, Traverse-Glehen A, Mendiola M, Pozo-Kreilinger JJ, Caux C, Tommasino M, Goutagny N, Hasan UA. Parroche P, et al. Among authors: goutagny n. Oncogenesis. 2016 Jul 25;5(7):e244. doi: 10.1038/oncsis.2016.49. Oncogenesis. 2016. PMID: 27454079 Free PMC article.
Human natural killer cells promote cross-presentation of tumor cell-derived antigens by dendritic cells.
Deauvieau F, Ollion V, Doffin AC, Achard C, Fonteneau JF, Verronese E, Durand I, Ghittoni R, Marvel J, Dezutter-Dambuyant C, Walzer T, Vie H, Perrot I, Goutagny N, Caux C, Valladeau-Guilemond J. Deauvieau F, et al. Among authors: goutagny n. Int J Cancer. 2015 Mar 1;136(5):1085-94. doi: 10.1002/ijc.29087. Epub 2014 Aug 6. Int J Cancer. 2015. PMID: 25046660 Free article.
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment.
Le Mercier I, Poujol D, Sanlaville A, Sisirak V, Gobert M, Durand I, Dubois B, Treilleux I, Marvel J, Vlach J, Blay JY, Bendriss-Vermare N, Caux C, Puisieux I, Goutagny N. Le Mercier I, et al. Among authors: goutagny n. Cancer Res. 2013 Aug 1;73(15):4629-40. doi: 10.1158/0008-5472.CAN-12-3058. Epub 2013 May 30. Cancer Res. 2013. PMID: 23722543 Free article.
29 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page